Back to the main directory
EarningsReview / Equity
- Margin beat offsets topline miss; gearing up to leverage ECMS by BNP Paribas Exane
- H World Group (HTHT US) by HSBC
- CMD feedback - upside if Sandvik can deliver on its targets by BNP Paribas Exane
- Curve your enthusiasm by BNP Paribas Exane
- F3Q:25 First Look: Palo Alto saw weakness in April but now back on track by BNP Paribas Exane
- Zydus Lifesciences (ZYDUSLIF IN) by HSBC
- Petronet Lng Ltd (PLNG IN) by HSBC
- Specialty Investor Day Feedback: mgmt. confident on its 2028 targets by BNP Paribas Exane
- Public Property Invest - In growth mode by Danske Bank Equity Research
- Rockwool - Hold: Slowing demand, but also conservative guidance by Nordea
- Lagercrantz - Buy/SEK 300: Operational performance remains robust by Nordea
- H+H International - Hold: Not a lot of drama with Q1 numbers by Nordea
- 1Q Model Sweep: BEP, HASI, CWEN, XIFR, NPI, AMRC by BNP Paribas Exane
- Glimmering through the gloom by BNP Paribas Exane
- Q1-25 First Take by BNP Paribas Exane
- Q425 rev / EBITDA beat, no FY26 outlook (as expected), US/China tariff exposure quantified at 12% revenue by BNP Paribas Exane
- Nanoform - ASD deals forming but with limited near-term impact by Danske Bank Equity Research
- Trading update - slower topline, better margins by BNP Paribas Exane
- HSBC Life UK potentially for sale by BNP Paribas Exane
- Guinness Investor Day: good things come to those who wait by BNP Paribas Exane
- FY results first take: in line trading, no FY26 guide by BNP Paribas Exane
- SSE FY25 results first take by BNP Paribas Exane
- FY25 Results: Positive outlook by BNP Paribas Exane
- H1-25 first take by BNP Paribas Exane
- FY results first take: some cyber clarity by BNP Paribas Exane